2) Abstract:
The abstract is not well balanced. Background needs revisions. Results also need revisions in order for them to support the conclusion.
3) Study objective: Suggest that the following secondary aim be included: "To investigate the incidence of TB in relation to years of follow-up." 4) Method: Study population and eligibility criteria:
• Were patients taking anti-tuberculosis treatment at the time of enrollment excluded from the study? Measurement and study variable:
• If yes to the above question, then the definition of incident TB should be revised. If no, then the authors should consider including prevalent TB as a study outcome.
• Also no mention of years of follow-up variable and how it was categorised. Sample size and sampling procedure: What is the site size (i.e. numbers of HIV-infected patients from each selected facilities) Data Processing and Analysis: • Page 7 line 53 "SPSS version 20…" should read "SPSS version 20.0 software (SPSS Inc., Chicago, IL)…"
• From Page 7 line 53 to Page 8 line 5 is unclear. Also no mention of Kaplan-Meier estimates and log-rank test but these were mentioned in the results section. Suggest revising to "Descriptive statistics were used to characterize the socio-demographic and clinical variables. The event of interest was TB incidence. The incidence of TB (measured by incidence rate and incidence density rate) was stratified by socio-demographic and clinical variables. Kaplan-Meier estimates were used to describe time to event distributions. Log-rank tests were used to compare time-to-event across the different categories."
5) Results:
• Suggest adjusting the cox regression models by years of follow-up and health facility.
• A statistician may need to be consider the statistical approach to manage site differences.
• Insert May before 2015 on page 8 line 39.
• On page 12 line 14. "Three-forths" should read "Three-quarters".
• On page 12 line 19 "The incidence of TB was 105 and 14" should read "The incidence of TB was 105 cases and 14 cases" • Consider adding a consort diagram to describe: 1) people registered from July 2010 to June 2011; 2) patients excluded from analysis; 3) patients eligible for analysis; 4) the number of incident TB cases at the end of follow-up and 5) those who died and those who were lost to follow-up etc.
• Combine table 1 and 2. Please correct spelling in table 2 from izonized preventive therapy" to "isoniazid preventive therapy".
• Combine table 3 and 4. Please correct spelling in table 4 from izonized preventive therapy" to "isoniazid preventive therapy".
• Figure 1 : What does the abbreviation LOFPinm stand for? Is it length of follow-up in months? If so say it in full. Please include log rank test p-value.
• Figure 2 : What does the abbreviation LOFPinm stand for? Is it length of follow-up in months? If so say it in full. Please include log rank test p-value.
• Mention the finding on page 20 line 51 -53 in discussion section regarding hemoglobin level <10, 10 -12.5 and >12.5 g/dL • This might be a personal preference, but the brackets with adjusted hazard ratios and 95% CI should be as follows: (AHR 1.62, 95% CI 1.09 -2.39), for example on page 17 line 30. This goes for the entire manuscript).
• This might be personal preference, put use cells/µL and g/dL throughout the manuscript. 6) Discussion:
• As mentioned previously, page 20 line 51 -53: New result mentioned in discussion which was not mentioned in results section.
• Perhaps not necessary to mention the sentence on page 21 line 7-9. Tables: Table 3 and 4 not mentioned in text. Checklist: The STROBE checklist seems appropriate to use, as the authors completed the STROBE items only and not the record items. Please correct.
Minor compulsory revisions 1) Acronyms and abbreviations in text should be spelled out the first time they are used. 2) Numbers in text and tables should correspond to each other. Relevant for numbers (including percentages and adjusted hazard ratios) in page 2 line 27, page 8 line 55, page 10 line 7, page 10 line 16 and page 17 line 30. 3) Page 4 line 5 mycobacterium tuberculosis should be italicized. 4) Page 22 line 9 as well as page 31 line 29 -30: "up on the request" should read "upon request". 5) The standard of English needs to be improved throughout, the manuscript (including checklist) would benefit from a thorough proof read by a third party (preferably a native English speaker) to improve grammar and correct typos. The grammatical and typos errors distract from the overall quality of the work. 6) Also be consistent with abbreviations. For example is IPT isoniazid preventive therapy or isoniazid prophylaxis therapy as mentioned on page 10 line 48. The manuscript has the potential to contribute to the understanding of TB-HIV co-infection in sub-Saharan Africa, specifically Ethiopia which has one of the highest TB infection rates in the region. However, there are a number of major and minor concerns I have regarding this manuscript which I have listed below.
My overall assessment of this manuscript is that major revisions are required.
MAJOR CONCERNS:
Introduction: No major concerns.
Methods: 1. As there was no culture confirmation of TB infection (which is the gold standard for diagnosis), I would think that the "TB cases" in the study should be considered "possible" or "probable". The author would need to clarify this in the methodology.
2. I feel that categories for the variable "Functional status" are not appropriate. This should simply be "bedridden -yes or no". This would require the analysis to be redone.
3. For the haemoglobin variable, the authors should bear in mind that haemoglobin differs amongst men and women. The authors should consider using the anaemia threshold recommended by WHO as this accounts for gender-based differences in haemoglobin between men and women. This would require the analysis to be redone.
4. There is no variable which addresses "TB contacts" (ie. other family member/co-inhabitant with TB) in the household. The authors should include this in the analysis if possible, but if no data exists then it will need to be listed as a limitation in the discussion section.
Results: 1. For the cox regression I suggest that "No" be made the reference group for IPT. It is more practical as IPT use is "protective". This requires the analysis to be redone.
Discussion: 1. Paragraph 2 of the discussion relates to the incidence of TB in the study and how this differs from other settings/countries. The author has mentioned several patient and health systems factors from the literature which might play a role in the observed difference in TB incidence between settings. However, there is no recommendation of how these patient/health systems factors can potentially be addressed in the author's setting.
2. Again, importance of prior history of TB and IPT has been outline on page 20 (line 1-12), however no recommendations are made (ie. specific checklists on medical histories so prior TB infection is properly documented, coordination between primary care and higher level clinics such that appropriate information in patient medical records are shared, mantoux tests to identify patients with TB exposure who would benefit from IPT, etc.).
3. For "bedridden" functional status, the potential impact of care givers with TB also needs to be discussed (in addition to malnutrition). Additionally, does there need to be a nutritional component in HIV care packages? Do care givers of bedridden/disabled patients need to be screened for TB?
4. For BMI findings, again does there need to be a nutritional component in care packages? What is the evidence (if any) which would support this?
5. As mentioned the WHO definition for anaemia should be used to present findings related to haemoglobin levels. Importance of identifying anaemia using traditional diagnostic laboratory tests or point-of-care technologies needs to be mentioned. Anaemia must be managed in HIV-infected patients considering poor prognoses related to TB infection.
6. A number of factors were not found to be associated with incident TB in this study. The authors have failed to discuss why these factors were not found to be associated with incident TB in their study. Is there any published evidence, or can the authors provide their own explanation regarding these "negative" findings?
6. How do the findings of this study differ from published studies of other regions of Ethiopia? For example, the authors did not find CD4 count and WHO disease stage to be associated with incident TB. This is in contrast to Gudina and Gudissa who found these two variables to be significantly associated with TB infection in Jimma (Pan Afr Med J. 2013; 14: 126.). Does this perhaps point to potential geographic differences in risk factors between different geographic regions of Ethiopia?
7. One of the most serious limitations of this study has not been addressed in the limitations section of the manuscript -There was no culture confirmation of TB. This is extremely important as radiological and clinical diagnosis is subjective. In addition, ZN smears may not detect all patients with TB. That is why the "gold standard" of culture confirmation is required. What do the authors recommend in order to address this limitation?
MINOR CONCERNS:
Introduction: 1. The manuscript requires extensive language editing. The abstract alone has several grammatical errors, and this extends to the other sections of the manuscript.
2. It is general practice to first spell out the abbreviations in the manuscript text then use the abbreviated form on subsequent occasions (see IPT and CPT).
3. The introduction section is too long, and there is a sense of repetition. Out of the four paragraphs it would make sense to keep the last two paragraphs only as these seem to capture the problem statement and aim of the research.
4. There is no statement in the introduction which provides a deeper rationale for why this study was done. For instance one may say that it is important to know what variables are risk factors so that a better understanding of the aetiology of HIV-TB coinfection in the region can be gained. This can contribute to the development of interventions to reduce risk. However, this is missing in the manuscript introduction.
Methods: 1. The authors have selected patients from a series of clinics/hospitals which treat the majority of HIV-TB coinfected patients. However, this might have introduced selection bias in the study as they have excluded 15% of the HIV-TB population because they did not use the specified clinics/hospitals. This needs to be discussed in the limitations section of the manuscript.
2. BMI, WHO should be written out in full once, and thereafter abbreviations should be used.
3. The variable IPT use is not defined. 4. The variable "substance abuse" needs to be defined (does it include intravenous drug use, cannabis use, etc?) 5. A number of parameters are provided for the sample size calculation. However, how these parameters were arrived at is not explained. Were these parameters (for instance percentage of patients with incomplete data -3.3%) obtained from a pilot study or a previous study in the area?
Results: 1. I suggest that a flow diagram be included indicating how many patients were eligible for the study, how many were excluded (with reasons for exclusion), the final number in the study population, and subsequent patient outcomes. END OF REVIEW.
VERSION 1 -AUTHOR RESPONSE

AUTHOR RESPONSE FOR REVIEWER-1
Answer: Dear Reviewer, thank you very much for your critical contribution!
• The title is modified according to your suggestion.
• The background section in the abstract section revised based on the comment.
• I have included "The incidence of TB was investigated in relation to years of follow-up" as secondary outcome measure.
• Regarding the eligibility criteria, patients taking anti-tuberculosis treatment at the time of enrollment were excluded from the study.
• The word "SPSS version 20…" is now corrected as "SPSS version 20.0 software • The sentences in THE data analysis and processing sub-section that was unclear is corrected according to the suggestion.
• Years of follow-up is now included in the cox regression model and re-analysis is performed for the cox-regression model.
• In the result section, the month "May" is now inserted before the year 2015. It was corrected based on your suggestion.
• The phrase "Three-forths" is replaced by "Three-quarters".
• The phrase "The incidence of TB was 105 and 14" is corrected as "The incidence of TB was 105 and 14 cases"
• The flow diagram that describes the study selection is included in the result section.
• Now Table 1&2 are combined.
• The word "izonized" is corrected as "isoniazid" throughout the manuscript.
• Table 3 and 4 are combined.
• The abbreviation "LOFPinm" which was written in the figure is corrected in the new graph.
• Brackets with adjusted hazard ratios and 95% CI is corrected according to your suggestion.
• The units "cells/µL and g/dL" are corrected and used throughout the manuscript.
• New results which are mentioned in the discussion section are now corrected accordingly.
• The less important sentence in the discussion section on page 20 lines 7-9 was deleted.
• References are updated based on the comments and journal requirement.
• Tables are now merged and cited accordingly. • STROBE checklist is now corrected as appropriate.
• Acronyms and abbreviations are spelled out before the first time they are used.
• Numbers and texts correspond to each other.
• Mycobacterium tuberculosis in page 4 line 1 is italicized • The phrase "up on the request" is now corrected as "upon request".
• The language is improved throughout the manuscript.
• Now "isoniazid preventive therapy" is used throughout the manuscript.
AUTHOR RESPONSE FOR REVIEWER-2 Author response
Answer: Thank you dear for your relevant comments! Your comments were very useful to improve the manuscript, and I hope most of your comments are incorporated. Probably, if I have missed out your comments, I will accept your comments more.
• Regarding the cases of TB and diagnostic methods, even though the gold standard diagnostic method is culture, AFB and the histological findings are also methods of TB diagnosis in the study settings. In resource limited and high TB burden countries, it is unlikely to address all suspected TB cases with culture. On top of that, unlike the sputum culture, the smear microscopy is simple, rapid, and inexpensive and highly specific in areas where there is a high prevalence of TB like the study setting. As a result, other options such as smear microscopy can be used. It is also reported that the presence of acid-fast bacilli (AFB) on sputum smear indicates TB disease. In addition, the TB Control Program which was endorsed by WHO, reported that examinations of three sputum samples by ZN staining microscopy can be used for the diagnosis of tuberculosis. Reports also indicated that the first two sputum smear examinations could detect as much as more than 95% of the cases. However, as you indicated, smear microscopy has significant limitations in its performance. It was revealed that sensitivity is compromised if bacterial load is below 10,000 per ml of sputum. Therefore, inability to perform TB confirmation with the gold standard method (culture) is reported as the limitation of the study.
• The variable "functional status" is replaced by "bedridden" and re-analysis is done accordingly.
• The cut-off point for hemoglobin is modified according to WHO category and re-analysis is done for the descriptive and cox-regression model.
• Inability to address the variable "TB contacts" is mentioned as the limitation of the study. The authors didn't address this variable because it was not easy to get the variable in the study type.
• For the variable "IPT" the response "No" becomes the reference category and re-analysis is done.
• We have addressed significant variables in the recommendation section • Your suggestions to include recommendations such as "coordination between private and public health facilities to share appropriate information in patient medical record" and "mantoux tests to identify patients with TB exposure who would benefit from IPT" are included. Other recommendations are also made accordingly.
• Regarding the incidence of TB among bedridden functional status, care giver with TB might have their own impact for the development of TB among HIV positive people with bedridden functional status. In addition, the nutritional status of bedridden individuals might have great contribution for the incidence of TB. For the nutritional component in HIV care, individuals with BMI less than 18kg/m2 will get a minimum of two plumpy Nut sackets per day, to improve their nutritional status.
• Regarding the definition of anemia, WHO cut off point of 11mg/dL is used to present findings. Hemoglobin is usually measured as a part of the routine complete blood count (CBC) test from a blood sample. As a result, people with hemoglobin level below 11g/dL had a higher risk of developing TB; recommending management of anemia among HIV positive individuals is mandatory, and is now included in the manuscript.
• Regarding the variables which were not significant in this study, the geographic differences in risk factors between different geographic regions of Ethiopia might contribute for the difference.
• As you clearly mentioned, the limitation of the study was the fact that there was no culture confirmation of TB. With no doubt, culture test, gives the highest validity. Therefore, in further research that can include TB confirmation, culture is highly recommended.
• Language editing is performed by experts.
• Abbreviations are spelled out before they are used.
• The introduction section is made concise to focus only on the problem.
• The rationale of the study is now mentioned in the last paragraph of the introduction section.
• As you mentioned, patients were selected from health institutions that were providing for the majority (85%) of the HIV-TB population. The authors were forced to exclude 15% of HIV-TB due to inaccessibility of the study area due to feasibility and security problems. The exclusion of this population is no doubt the limitation of the study.
• Abbreviation are spell out before they are used.
• Isoniazid preventive therapy (IPT) use in this study was defined as a patient who took IPT for at least 3 months. The definition is now included in the measurement and study variables sub-section.
• In this study "substance use" is defined as use of at least one of the substances (alcohol, khat, cigarettes, and illicit drugs) in an individual's life time to alter mood or behavior. The definition is now included in the measurement and study variables sub-section.
• Regarding the parameters used for sample size calculations, for example, 3.3% of incomplete data that was taken from the study conducted in a similar setting in Ethiopia, the reference is duly cited. The other assumption used for sample size calculation was the incidence of TB among HIV positive cases as 17% was taken from a study conducted in Jimma and it is cited.
• The flow diagram indicating how patients were eligible is included in the result section • In this study, initially there were 503 patients who were enrolled in the selected health facilities from July 2010 to June 2017. However, about 52 patient charts were excluded due to incomplete information and 451 were qualified for analysis.
• Regarding the power of the study, off course, we planned to include all (503) patients enrolled in the selected health facilities. However, there were patients charts excluded from analysis because they didn't fulfill the inclusion criteria. To me, the overall sample size was adequate for the study setting, however, I feel that the statistical power to detect some important risk factors for TB incidence was limited due to the low overall incidence rate of TB.
• Kaplan-Meier curves with P-value for significant factors is now presented in the study • The first paragraph in the discussion attempted to indicate the primary objective of the study.
• As you mentioned, this study is conducted in a single region of Ethiopia, and it might not be generalizable to the other regions. This is included as a limitation of the study. As a recommendation, collaborative projects that can include several regions of the country are desirable.
• Regarding private health facilities, off course, there are private health institutions in the region; however, during the study period they didn't start TB-HIV care services. The service was given by a governmental health facility; that is why we didn't include the private health institutions at the time. But at this time, private health institutions have started the service and future research on the incidence of TB among HIV positive individuals should include them. 
GENERAL COMMENTS
I appreciate the efforts made by the authors to strengthen the manuscript. As a consequence this version is much improved. Below are minor compulsory revisions that need to be addressed. 1. In general, acronyms and abbreviations in text should be spelled out the first time they are used. I still see inconsistencies in this version of the manuscript.
2. In the abstract section Page 2 line 28 spell out AHR in full.
3. Re-phrase the sentence in the method section Page 6 lines 20 to 25 for better reading.
4. Since the analyses were redone with bedridden functional status only, then the sentence on page 6 line 52 to 28 should be revised accordingly. The authors need to address this inconsistency.
5. In the methods section Page 7 line 27 the authors state that 503 records were included in the study. Then in the results section Page 8 line 52 the authors state hat only 451 patients were included in the analysis. The authors need to clarify this in the manuscript.
6. In the results section page 8 line 52 the authors state that " a total of 451 records of PLHIV enrolled in health facilities…" while in Figure 1 shows that 503 PLHIV were registered. The authors need to address this inconsistency.
7. Suggest rephrasing the results for the survival analysis mentioned on Page 12 lines 35 to 46, as follows for better reading: There was a significant difference in the survival curves of patients underweight and those not (p<0.002); among the different WHO clinical stage categories (P<0.001); among patients with anemia and those without (p<0.001); among patients bedridden and those not (p<0.002); and patients receiving IPT and those not (P<0.0001).
8. In the discussion section, the author need to mention the introduction of selection bias due to the exclusion of patients who did not use the clinics/hospitals chosen.
9. subjects who were bedridden at baseline crossed with marital status, family size, and so on), the conclusions might be misleading.
4.
Were there any repeated TB infections from same subjects over the 5 study period? If yes, within-subject correlation might need be considered.
5. Line 12-14 on Pg 12, one place says 114 of the TB incidents occurred in the first one year of follow-up, and then 68 within the first year of follow up. Please check the numbers and rephrase the results.
6. Line 22 on Pg 15, is it a typo to use "underweight"?
7. Table 1 is redundant with all its contents were presented in Table  2 as well.
VERSION 2 -AUTHOR RESPONSE
Reviewer-1 Minor compulsory revisions 1. In general, acronyms and abbreviations in text should be spelled out the first time they are used. I still see inconsistencies in this version of the manuscript.
Answer: Dear Reviewer, thank you very much for your critical contribution! • Now acronyms and abbreviations are spelled out the first time they are used. Answer: Thank you again! • As you stated, since bedridden functional status is reanalyzed, the sentence is revised and inconsistencies are corrected accordingly (page 6 line 31 to page 7 lines 1-3).
5. In the methods section Page 7 line 27 the authors state that 503 records were included in the study. Then in the results section Page 8 line 52 the authors state hat only 451 patients were included in the analysis. The authors need to clarify this in the manuscript. Answer: Thank you! • Regarding the study population included in the study, among the total 503 PLHIV registered in the selected hospital, records with complete information were included for analysis. And a total 451 patients with complete information were followed, while the rest 52 records were excluded from analysis because of incomplete information (page 9 lines 3-7).
6. In the results section page 8 line 52 the authors state that " a total of 451 records of PLHIV enrolled in health facilities…" while in Figure 1 shows that 503 PLHIV were registered. The authors need to address this inconsistency. Answer: Thank you! • Off course figure-1 showed how study participants are selected and it illustrated that initially there were a total of 503 PLHIV were registered from July 2010 to June 2011 in the selected health facilities. While 52 records with incomplete information are excluded from analysis, and 451 charts with complete information were included. 8. In the discussion section, the author need to mention the introduction of selection bias due to the exclusion of patients who did not use the clinics/hospitals chosen. Answer: Thank you again! • As you clearly stated, inability to include patients who did not use the selected hospitals can introduce selection bias and it is mentioned in the discussion section as the limitation of the study (page 19 lines 21-22) 9. 10. Table 3 abbreviations need to be spelled out at the bottom of the table.
• Abbreviations at the bottom of table 3 is spelled out in full (page 17 lines 1-3)
